These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 29934804)

  • 1. New Approach for the Application of USP Apparatus 3 in Dissolution Tests: Case Studies of Three Antihypertensive Immediate-Release Tablets.
    Espíndola B; Bortolon FF; Pinto JMO; Pezzini BR; Stulzer HK
    AAPS PharmSciTech; 2018 Oct; 19(7):2866-2874. PubMed ID: 29934804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanistic Approach to Understanding the Influence of USP Apparatus I and II on Dissolution Kinetics of Tablets with Different Operating Release Mechanisms.
    Lu Z; Fassihi R
    AAPS PharmSciTech; 2017 Feb; 18(2):462-472. PubMed ID: 27106916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of USP apparatus 3 for dissolution testing of immediate-release products.
    Yu LX; Wang JT; Hussain AS
    AAPS PharmSci; 2002; 4(1):E1. PubMed ID: 12049485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the usefulness of compendial setups and tiny-TIM system in evaluating the in vivo performance of oral drug products with various release profiles in the fasted state: Case example sodium salt of A6197.
    Schilderink R; Protopappa M; Fleth-James J; Vertzoni M; Schaefer K; Havenaar R; Kulla I; Metzger M; Reppas C
    Eur J Pharm Biopharm; 2020 Apr; 149():154-162. PubMed ID: 32057905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing Drug Release from Manipulated Abuse Deterrent Formulations.
    Feng X; Zidan A; Kamal NS; Xu X; Sun D; Walenga R; Boyce H; Cruz CN; Ashraf M
    AAPS PharmSciTech; 2020 Jan; 21(2):40. PubMed ID: 31897805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of dissolution profiles for albendazole tablets using USP apparatus 2 and 4.
    Hurtado y de la Peña M; Vargas Alvarado Y; Domínguez-Ramírez AM; Cortés Arroyo AR
    Drug Dev Ind Pharm; 2003 Aug; 29(7):777-84. PubMed ID: 12906335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Typical variability in drug dissolution testing: study with USP and FDA calibrator tablets and a marketed drug (glibenclamide) product.
    Qureshi SA; McGilveray IJ
    Eur J Pharm Sci; 1999 Feb; 7(3):249-58. PubMed ID: 9845813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of floating and sticking extended release delivery systems: an unconventional dissolution test.
    Dürig T; Fassihi R
    J Control Release; 2000 Jun; 67(1):37-44. PubMed ID: 10773327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of basket mesh size on the hydrodynamics of a partially filled (500 mL) USP rotating basket dissolution testing Apparatus 1.
    Sirasitthichoke C; Patel S; Reuter KG; Hermans A; Bredael G; Armenante PM
    Int J Pharm; 2024 Jun; 658():124209. PubMed ID: 38718973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling and comparison of release profiles: Effect of the dissolution method.
    Cascone S
    Eur J Pharm Sci; 2017 Aug; 106():352-361. PubMed ID: 28627469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Coadministered Water on the In Vivo Performance of Oral Formulations Containing N-Acetylcysteine: An In Vitro Approach Using the Dynamic Open Flow-Through Test Apparatus.
    Sager M; Schneider F; Jedamzik P; Wiedmann M; Schremmer E; Koziolek M; Weitschies W
    Mol Pharm; 2017 Dec; 14(12):4272-4280. PubMed ID: 29064257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of the Oral Pharmacokinetics and Food Effects of Gabapentin Enacarbil Extended-Release Tablets Using Biorelevant Dissolution Tests.
    Yamaguchi Ikeuchi S; Kambayashi A; Kojima H; Oku N; Asai T
    Biol Pharm Bull; 2018; 41(11):1708-1715. PubMed ID: 30381671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissolution testing of modified release products with biorelevant media: An OrBiTo ring study using the USP apparatus III and IV.
    Reppas C; Vrettos NN; Dressman J; Andreas CJ; Miyaji Y; Brown J; Etherson K; Hanley S; Karkossa F; Karlsson E; Klein S; Maier GM; McAllister M; Mistry N; Rosenblatt K; Schäfer KJ; Smith KL; Tomaszewska I; Williams J; Winge F; Vertzoni M
    Eur J Pharm Biopharm; 2020 Nov; 156():40-49. PubMed ID: 32882421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irregular absorption profiles observed from diclofenac extended release tablets can be predicted using a dissolution test apparatus that mimics in vivo physical stresses.
    Garbacz G; Wedemeyer RS; Nagel S; Giessmann T; Mönnikes H; Wilson CG; Siegmund W; Weitschies W
    Eur J Pharm Biopharm; 2008 Oct; 70(2):421-8. PubMed ID: 18582568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A better dissolution method for ranitidine tablets USP.
    Cappola ML
    Pharm Dev Technol; 2001; 6(1):11-7. PubMed ID: 11247270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro dissolution methodology, mini-Gastrointestinal Simulator (mGIS), predicts better in vivo dissolution of a weak base drug, dasatinib.
    Tsume Y; Takeuchi S; Matsui K; Amidon GE; Amidon GL
    Eur J Pharm Sci; 2015 Aug; 76():203-12. PubMed ID: 25978875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding the impact of media viscosity on dissolution of a highly water soluble drug within a USP 2 mini vessel dissolution apparatus using an optical planar induced fluorescence (PLIF) method.
    Stamatopoulos K; Batchelor HK; Alberini F; Ramsay J; Simmons MJH
    Int J Pharm; 2015 Nov; 495(1):362-373. PubMed ID: 26363111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of higher rates of agitation on release patterns of immediate-release drug products.
    Shah VP; Gurbarg M; Noory A; Dighe S; Skelly JP
    J Pharm Sci; 1992 Jun; 81(6):500-3. PubMed ID: 1522485
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Medina-López R; Guillén-Moedano S; Hurtado M
    ADMET DMPK; 2020; 8(4):411-423. PubMed ID: 35300193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined study of biphasic and zero-order release formulations with dissolution tests and ATR-FTIR spectroscopic imaging.
    Wray P; Li J; Li LQ; Kazarian SG
    J Pharm Sci; 2014 Jul; 103(7):1995-2004. PubMed ID: 24801351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.